195 related articles for article (PubMed ID: 30368933)
1. Predictive ability of renal cortex enhancement in dynamic computed tomography for residual renal function after nephroureterectomy: Comparison with
Waseda Y; Saito K; Ishikawa Y; Kawano K; Yokoyama M; Ishioka J; Matsuoka Y; Morimoto S; Kihara K; Fujii Y
Int J Urol; 2019 Feb; 26(2):266-272. PubMed ID: 30368933
[TBL] [Abstract][Full Text] [Related]
2. Prediction of renal function after nephroureterectomy in patients with upper tract urothelial carcinoma.
Hashimoto T; Ohno Y; Nakashima J; Gondo T; Nakagami Y; Namiki K; Horiguchi Y; Yoshioka K; Ohori M; Tachibana M
Jpn J Clin Oncol; 2015 Nov; 45(11):1064-8. PubMed ID: 26355160
[TBL] [Abstract][Full Text] [Related]
3. The effect of contralateral kidney volume on renal function after radical nephroureterectomy: Implications for eligibility for neoadjuvant chemotherapy for upper tract urothelial cancer.
Song W; Sung HH; Han DH; Jeong BC; Seo SI; Jeon SS; Lee HM; Choi HY; Jeon HG
Urol Oncol; 2017 Mar; 35(3):114.e1-114.e7. PubMed ID: 27908680
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant chemotherapy after radical nephroureterectomy does not improve survival in patients with upper tract urothelial carcinoma: a joint study by the European Association of Urology-Young Academic Urologists and the Upper Tract Urothelial Carcinoma Collaboration.
Necchi A; Lo Vullo S; Mariani L; Moschini M; Hendricksen K; Rink M; Sosnowski R; Dobruch J; Raman JD; Wood CG; Margulis V; Roupret M; Briganti A; Montorsi F; Xylinas E; Shariat SF;
BJU Int; 2018 Feb; 121(2):252-259. PubMed ID: 28940605
[TBL] [Abstract][Full Text] [Related]
5. Potential of Perfusion Magnetic Resonance Imaging to Predict Residual Renal Function after Radical Nephroureterectomy.
Waseda Y; Yoshida S; Arita Y; Takahara T; Sakamoto T; Saito K; Fujii Y
Urol Int; 2021; 105(5-6):507-513. PubMed ID: 33626549
[TBL] [Abstract][Full Text] [Related]
6. Risk factors associated with ineligibility of adjuvant cisplatin-based chemotherapy after nephroureterectomy.
Shao IH; Lin YH; Hou CP; Juang HH; Chen CL; Chang PL; Tsui KH
Drug Des Devel Ther; 2014; 8():1985-90. PubMed ID: 25364228
[TBL] [Abstract][Full Text] [Related]
7. Clinical application of calculated split renal volume using computed tomography-based renal volumetry after partial nephrectomy: Correlation with technetium-99m dimercaptosuccinic acid renal scan data.
Lee CH; Park YJ; Ku JY; Ha HK
Int J Urol; 2017 Jun; 24(6):433-439. PubMed ID: 28332239
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of gamma camera-based GFR measurement using renal depth evaluated by lateral scan of
Sugawara S; Ishii S; Kojima Y; Ito H; Suzuki Y; Oriuchi N
Ann Nucl Med; 2020 May; 34(5):349-357. PubMed ID: 32166712
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Systemic Chemotherapy Plus Radical Nephroureterectomy for Metastatic Upper Tract Urothelial Carcinoma.
Seisen T; Jindal T; Karabon P; Sood A; Bellmunt J; Rouprêt M; Leow JJ; Vetterlein MW; Sun M; Alanee S; Choueiri TK; Trinh QD; Menon M; Abdollah F
Eur Urol; 2017 May; 71(5):714-718. PubMed ID: 27912971
[TBL] [Abstract][Full Text] [Related]
10. The renal safety and efficacy of combined gemcitabine plus cisplatin and gemcitabine plus carboplatin chemotherapy in Chinese patients with a solitary kidney after nephroureterectomy.
Sun P; Xue C; Li LR; Shao C; An X; Thomas R; Yang W; Deng YF; Jiang WQ; Shi YX
Cancer Chemother Pharmacol; 2017 Jul; 80(1):37-44. PubMed ID: 28534209
[TBL] [Abstract][Full Text] [Related]
11. Smaller decline of renal function after nephroureterectomy predicts poorer prognosis of upper tract urothelial carcinoma: a multicentre retrospective study.
Yamada Y; Nakagawa T; Miyakawa J; Kawai T; Tabata M; Kaneko T; Taguchi S; Naito A; Hikatsu M; Sato Y; Murata T; Matsumoto A; Miyazaki H; Suzuki M; Enomoto Y; Nishimatsu H; Kondo Y; Takeuchi T; Tanaka Y; Kume H
Jpn J Clin Oncol; 2021 Oct; 51(10):1577-1586. PubMed ID: 34047345
[TBL] [Abstract][Full Text] [Related]
12. Computed tomography for detection and staging of transitional cell carcinoma of the upper urinary tract.
Planz B; George R; Adam G; Jakse G; Planz K
Eur Urol; 1995; 27(2):146-50. PubMed ID: 7744157
[TBL] [Abstract][Full Text] [Related]
13. A role for preoperative systemic chemotherapy in node-positive upper tract urothelial carcinoma treated with radical nephroureterectomy.
Kitamura H; Igarashi M; Tanaka T; Shindo T; Masumori N; Tamakawa M; Kawaai Y; Tsukamoto T
Jpn J Clin Oncol; 2012 Dec; 42(12):1192-6. PubMed ID: 23077244
[TBL] [Abstract][Full Text] [Related]
14. Clinical practice patterns for upper tract urothelial carcinoma: a nationwide survey in Japan.
Kikuchi E; Oya M
Jpn J Clin Oncol; 2016 Aug; 46(8):768-74. PubMed ID: 27272173
[TBL] [Abstract][Full Text] [Related]
15. Preoperative predictors of renal function decline after radical nephroureterectomy for upper tract urothelial carcinoma.
Kaag M; Trost L; Thompson RH; Favaretto R; Elliott V; Shariat SF; Maschino A; Vertosick E; Raman JD; Dalbagni G
BJU Int; 2014 Nov; 114(5):674-9. PubMed ID: 24314050
[TBL] [Abstract][Full Text] [Related]
16. Renal safety and efficacy of cisplatin-based chemotherapy in patients with a solitary kidney after nephroureterectomy for urothelial carcinoma of the upper urinary tract.
Cho KS; Joung JY; Seo HK; Cho IC; Chung HS; Chung J; Lee KH
Cancer Chemother Pharmacol; 2011 Apr; 67(4):769-74. PubMed ID: 20532510
[TBL] [Abstract][Full Text] [Related]
17. The assessment of renal cortex and parenchymal volume using automated CT volumetry for predicting renal function after donor nephrectomy.
Mitsui Y; Sadahira T; Araki M; Wada K; Tanimoto R; Ariyoshi Y; Kobayashi Y; Watanabe M; Watanabe T; Nasu Y
Clin Exp Nephrol; 2018 Apr; 22(2):453-458. PubMed ID: 28741049
[TBL] [Abstract][Full Text] [Related]
18. Renal function recovery after radical nephroureterectomy for upper tract urothelial carcinoma.
Lee BH; Zabor EC; Tennenbaum D; Furberg H; Benfante N; Coleman JA; Jaimes EA; Russo P
World J Urol; 2018 Feb; 36(2):257-263. PubMed ID: 29209771
[TBL] [Abstract][Full Text] [Related]
19. Survival effect of perioperative systemic chemotherapy on overall mortality in locally advanced and/or positive regional lymph node non-metastatic urothelial carcinoma of the upper urinary tract.
Nazzani S; Preisser F; Mazzone E; Tian Z; Mistretta FA; Shariat SF; Soulières D; Saad F; Montanari E; Luzzago S; Briganti A; Carmignani L; Karakiewicz PI
World J Urol; 2019 Jul; 37(7):1329-1337. PubMed ID: 30298285
[TBL] [Abstract][Full Text] [Related]
20. [Role of computerized tomography in the diagnosis of transitional cell carcinoma of the upper urinary tract].
Negru D; Ghiorghiu DC; Reuţ R; Negru I; Pricop C; Novac C; Daniil C
Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):613-7. PubMed ID: 14756072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
